Invention Grant
- Patent Title: Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI)
-
Application No.: US16754912Application Date: 2018-10-09
-
Publication No.: US11351144B2Publication Date: 2022-06-07
- Inventor: Igor Garkavtsev , Rakesh K. Jain
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2018/054957 WO 20181009
- International Announcement: WO2019/074895 WO 20190418
- Main IPC: A61K31/16
- IPC: A61K31/16 ; A61P35/00 ; A61K31/245 ; A61P35/04 ; A61K45/06
Abstract:
This invention relates to compounds that are useful for inhibiting the secretion of secretory leukocyte protease inhibitor (SLPI) in a subject. Methods of inhibiting metastasis of cancer and methods of treating cancer in a subject are also provided.
Public/Granted literature
- US20210196666A1 Compounds For Inhibiting Secretory Leukocyte Protease Inhibitor (SLPI) Public/Granted day:2021-07-01
Information query
